Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women��s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer��s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

OptumInsight, Inc. provides healthcare information technology and consulting services. It offers technology services, information, analytics, business services and consulting to help solve the most important problems clients face across the health system. The firm provides solutions for physicians, hospitals, life sciences companies, government agencies and other organizations that comprise the health care system. The company is headquartered in St. Paul, MN.

MediResource has been a leader in the online application of consumer health care information and digital tools since 1996. As a publisher, MediResource produces a comprehensive library of health information and drug and disease databases which engage millions of consumers on a monthly basis. Providing an industry-leading platform for health and wellness, allowing MediResource to distribute sophisticated, user-friendly information and digital tools across all touch points, including online, mobile and point of care. Ultimately MediResource helps their clients leverage their technology to efficiently reach or manage large consumer patient populations to achieve effective behavior change that improves outcomes.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud, and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

Shanghai Taoshu Biotechnology Co., Ltd., established on 2013-04-18, Business scope includes general items:Engaged in technology development in the professional field of biotechnology,technical consulting,technology transfer,Technical Services,Instrumentation,Green facilities,Electrical Equipment,metallic material,Wujinjiaodian,Equipment,Electronic Component,communication equipment,plastic products,Daily necessities,textile,Chemical Products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Sales of Class II Medical Devices,Engaged in the import and export of goods and technology,Business Consulting,Investment Advisory.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan.

Epidauros Biotechnologie AG, part of AbbVie, Inc., is a German company located in Bernried. The firm specializes in pharmacogenomics research. Clinical Data BV acquired Epidauros Biotechnologie AG from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Xi'an Aolitai Pharmaceutical Technology Co., Ltd., established on 2017-08-11, Business scope includes biomedical technology research;Technology development of drugs and pharmaceutical intermediates,technology transfer,Technical Consulting and Technical Services;Sales of pharmaceutical intermediates;Biopharmaceutical R&D,Production,Sales;commission agent(except auction).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Hepu Pharmaceutical Co., Ltd., established on 2013-11-25, The scope of business includes engaging in technology development in the professional field of medicine,technology transfer,Technical service and technical consultation. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

BOE Technology Group Co., Ltd. provides intelligent interface products and services for information interaction and human health as an Internet-of-Things company. It operates through three segments, namely Display Device and Sensor Device Business, Smart System Business, and Healthcare Service Business. Display Device and Sensor Device Business segment offers display, senor, and application solutions. Smart System Business segment provides intelligent manufacturing services, Internet-of-Things solutions, and a digital art Internet-of-Things platform. Healthcare Service Business segment offers a mobile healthcare Internet-of-Things platform and smart healthcare services. The company was founded on April 9, 1993 and is headquartered in Beijing, China.

Certa Dose is a medical device company that offers an intuitive system that uses color confirmation to deliver accurate dosing. Its first product is a U.S. Food and Drug Administration-cleared syringe for use with the administration of epinephrine to pediatric patients. Each syringe is labeled with easy to recognize color zones that match the industry-standard Broselow pediatric color-coding system to help clinicians verify the correct dose during critical, time-sensitive situations. Users match the patient to a zone on the color scale and administer the medication to the corresponding color on the Certa Dose syringe. The patented syringe incorporates the right dose, the right concentration, and the right route of administration of medication dosing, along with a color-matching technology that creates an easy-to-use system focused on saving children’s lives by curbing critical medication errors

Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer's disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression. The company was incorporated in 1997 and is based in Montvale, New Jersey. As of December 31, 2008, Memory Pharmaceuticals Corp. operates as a subsidiary of Hoffmann-La Roche Inc.

Henan Dongpeptide Biological Co., Ltd., established on 2016-06-16, Business scope includes general items:Research and development of bio-based materials technology;Biochemical product technology research and development;Manufacturing of bio-based materials;Manufacturing of daily chemical products;Business Management Consulting;Purchase of primary agricultural products;Grain Purchase;Import and export;Technology Import and Export;Food import and export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:beverage production;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Second People's Hospital of Nanning (doing business as Nanning No. 2 People's Hospital), part of Guangxi Medical University, is a Chinese company located in Nanning. The firm provides healthcare services.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Suzhou Biyi Bicheng Pharmaceutical Technology Co., Ltd., established on 2017-05-16, Business scope includes pharmaceutical,Technology development in the field of biohealth technology,Technical Services,technology transfer;Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Pharmaceutical Intermediates(In addition to drugs),cosmetic,Packaging Materials,laboratory consumables,Instrumentation,electronic product,Sales of food additives;data processing services;translation service,Medical Research and Trial Development Consulting Services;Engaged in the import and export of goods and technology,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)